Hypertension, Vol 6, 689-699, Copyright © 1984 by American Heart Association
JC Kleinjans, JF Smits, H van Essen, CM Kasbergen and HA Struyker Boudier
The present study was designed to determine the hemodynamic changes
underlying the hypertension induced by chronic intrarenal infusion of
norepinephrine (NE) in conscious rats. NE was infused for a 5-day period
intrarenally with osmotic minipumps via a chronic catheter in the right
suprarenal artery at rates of 4 and 36 micrograms . kg-1 . hr- 1 or
intravenously at a rate of 36 micrograms . kg-1 . hr-1. Control rats
received a 1 microliter . hr-1 intrarenal infusion of pyrogen-free 0.9%
NaCl. In separate experiments, short-term effects were measured
continuously during a 22- to 24-hour intrarenal infusion of 4 and 36
micrograms NE . kg-1 . hr-1 or intravenous infusion of 36 micrograms NE .
kg-1 . hr-1. Intrarenal infusion of NE produced a more pronounced long-term
hypertensive effect than infusion of the same dose intravenously. This
hypertension was characterized by a rapid and sustained increase in total
peripheral resistance index (TPRI). Despite of the initial renal
vasoconstriction, specifically produced during the first 24 hours of
intrarenal NE application, cardiac index (CI) in parallel to stroke volume
index (SVI) decreased significantly during intrarenal as well as during
intravenous NE infusion. Furthermore, no signs of sodium retention were
observed. Both rates of intrarenal NE infusion have been shown previously
to produce a significant long-term increase in plasma potassium
concentration, and the present study indicates that this is presumably the
result of decreased urinary potassium output. It is concluded that chronic
hypertension produced by intrarenal or intravenous infusion is not
volume-dependent. The relatively greater increase in TPRI during intrarenal
NE infusion is attributed to vascular wall receptor sensitization by
increased plasma potassium levels resulting from effects of intrarenally
present NE on tubular cation exchange mechanisms.
ARTICLES
Hemodynamic characterization of hypertension induced by chronic intrarenal or intravenous infusion of norepinephrine in conscious rats
This article has been cited by other articles:
![]() |
V. H. Gattone II, T. M. Siqueira Jr, C. R. Powell, C. M. Trambaugh, J. E. Lingeman, and A. L. Shalhav Contribution of Renal Innervation to Hypertension in Rat Autosomal Dominant Polycystic Kidney Disease Experimental Biology and Medicine, August 1, 2008; 233(8): 952 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Grisk and R. Rettig Interactions between the sympathetic nervous system and the kidneys in arterial hypertension Cardiovasc Res, February 1, 2004; 61(2): 238 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Grisk, H.-J. Rose, G. Lorenz, and R. Rettig Sympathetic-renal interaction in chronic arterial pressure control Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R441 - R450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. R. Hermans, H. van Essen, H. A. J. Struijker-Boudier, R. M. Johnson, F. Theeuwes, and J. F. M. Smits Pharmacokinetic Advantage of Intrapericardially Applied Substances in the Rat J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 672 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Plato and J. L. Osborn Chronic Renal Neuroadrenergic Hypertension Is Associated With Increased Renal Norepinephrine Sensitivity and Volume Contraction Hypertension, December 1, 1996; 28(6): 1034 - 1040. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |